Anurag Mantri appointed as President of Glenmark Pharmaceuticals
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
The President said that there is a need to spread more and more awareness regarding the causes, diagnosis and treatment of cancer
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
Our China operations continue under the leadership of the current General Manager of AstraZeneca China
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
Subscribe To Our Newsletter & Stay Updated